Login to Your Account

Earnings Roundup

Friday, May 6, 2011
Cadence Pharmaceuticals Inc., of San Diego, reported the company's first-ever revenue, with sales of recently launched Ofirmev (acetaminophen) injection, an intravenous formulation of acetaminophen, driving net revenue of $350,000.

To continue reading subscribe now to BioWorld Today

Learn More about BioWorld Today

Already a subscriber? Sign In or Buy now to activate your subscription